INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $364,000 | -17.8% | 13,013 | -52.1% | 0.05% | -33.8% |
| Q3 2020 | $443,000 | -10.9% | 27,171 | +53.9% | 0.07% | +29.8% |
| Q4 2018 | $497,000 | -36.2% | 17,651 | -34.8% | 0.06% | +32.6% |
| Q3 2018 | $779,000 | -41.7% | 27,084 | -24.1% | 0.04% | -34.8% |
| Q2 2018 | $1,336,000 | +496.4% | 35,680 | +527.0% | 0.07% | +450.0% |
| Q1 2018 | $224,000 | -85.3% | 5,691 | -87.9% | 0.01% | -87.0% |
| Q4 2017 | $1,520,000 | +64.1% | 46,906 | +57.8% | 0.09% | +46.0% |
| Q3 2017 | $926,000 | – | 29,734 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |